Paper

Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.

Published Oct 1, 2013 · T. Naftali, Lihi Bar-Lev Schleider, I. Dotan

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

289

Citations

Influential Citations

Full text Semantic Scholar

Abstract

Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Study Snapshot

Key takeawayTHC-rich cannabis significantly improved clinical symptoms in 10 out of 11 patients with active Crohn's disease, without side effects, despite not achieving remission.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.

References

Citations